The article discusses that the Prostate cancer is one of the most common cancers treated with radiotherapy (RT). Conventional RT (CRT) for low-risk patients usually involves 40-45 treatments given over eight or nine weeks. It mentions that several studies suggest that hypofractionated RT (HRT) fewer treatments but with a higher dose per treatmentmay produce a similar survival benefit.